CD40 and cancer: Thus, during severe infections cognate interactions lose their importance whereas the CD154–CD40 pathway still is instrumental for GC formation, underlining its role as therapeutic target in the treatment of autoimmune diseases 50 that in the developed countries represent the third leading causes for morbidity and mortality after cancer and heart disease 40.